Schonfeld Strategic Advisors LLC Replimune Group, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 981,235 shares of REPL stock, worth $11.7 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
981,235
Previous 158,291
519.89%
Holding current value
$11.7 Million
Previous $1.29 Million
582.99%
% of portfolio
0.06%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
155Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$120 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$111 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$66.6 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$58.3 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$56.4 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $590M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...